Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
16/4 12:24
Company Announcement Net sales of DARZALEX ® in the first quarter of 2024 totaled USD 2,692 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; April 16, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of...